NEW ORLEANS — In a pivotal appointment for the future of surgical research and education, Dr. Babak J. Mehrara has been inaugurated as the President of The Plastic Surgery Foundation (The PSF). The announcement, made during Plastic Surgery The Meeting—the American Society of Plastic Surgeons’ (ASPS) premier annual scientific conference—marks a new chapter for the organization, which serves as the philanthropic and intellectual engine behind global plastic surgery innovation.
Dr. Mehrara, a preeminent authority in oncologic reconstruction, officially assumed the presidency on October 12, 2025. He is slated to lead the organization through a transformative one-year term, concluding on October 18, 2026. His appointment arrives at a time when the field of plastic surgery is increasingly intersecting with complex oncology and regenerative medicine, requiring a leader with both deep clinical experience and a robust background in fundamental scientific research.
Main Facts: A Leader at the Intersection of Care and Discovery
The Plastic Surgery Foundation plays a critical role in the medical ecosystem, providing the financial and structural support necessary for groundbreaking research, clinical trials, and global humanitarian outreach. As president, Dr. Mehrara will be responsible for setting the strategic vision of the organization, managing its research grant portfolio, and fostering partnerships that bridge the gap between laboratory discovery and patient-side application.
Dr. Mehrara’s dual role as a high-level surgeon and a research scientist makes him uniquely qualified for this mandate. Currently serving as the Chief of the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center (MSK), he oversees one of the most sophisticated reconstructive departments in the world. He also holds the Peter G. Cordeiro Endowed Chair in the Department of Surgery, a position that underscores his commitment to excellence in surgical education and leadership.
His clinical focus—specifically in oncologic reconstruction—places him at the vanguard of patient recovery. By helping patients restore form and function following disfiguring cancer surgeries, Dr. Mehrara’s work is fundamental to the quality of life of thousands. His leadership of The PSF is expected to emphasize these values: pushing the boundaries of what is possible in reconstructive care while ensuring that the next generation of surgeons is equipped with the tools, funding, and ethical guidance to continue this work.
Chronology: The Path to the Presidency
Dr. Mehrara’s ascent to the presidency is the culmination of decades of contributions to the surgical community. His career trajectory has been defined by a relentless pursuit of knowledge, moving from rigorous academic training to the directorship of major research laboratories.
- Early Academic Foundation: Dr. Mehrara built his initial reputation as a clinician-scientist at Weill Cornell Medical College, where he currently serves as a Professor of Surgery. His work there bridged the divide between classroom pedagogy and the operating room.
- The MSK Tenure: At Memorial Sloan Kettering, Dr. Mehrara rose through the ranks to become the Chief of the Plastic and Reconstructive Surgery Service. It was here that his work on lymphatic biology began to garner international attention, setting the stage for his broader influence in the field.
- National Institutes of Health (NIH) Involvement: A hallmark of his career has been his ability to secure competitive federal funding. As the director of the NIH-funded Lymphatic Biology Laboratory, he has managed large-scale research projects that have redefined the understanding of lymphatic diseases.
- The PSF Transition: Prior to his appointment as president, Dr. Mehrara served in various advisory and committee roles within the ASPS and The PSF. His familiarity with the Foundation’s governance and its strategic goals allowed for a seamless transition when he assumed the presidency on October 12, 2025.
- The Year Ahead (2025–2026): Dr. Mehrara’s term is defined by a 12-month calendar aimed at expanding the Foundation’s grant capacity and enhancing international collaborative research, ending on October 18, 2026.
Supporting Data: The Impact of a Scientific Titan
To understand the weight of Dr. Mehrara’s leadership, one must look at the volume and impact of his scientific output. He has authored more than 400 peer-reviewed publications—a staggering number that places him in the top echelon of surgical academics. These publications do more than just record findings; they serve as the foundational literature for modern techniques in managing cancer-related lymphedema and complex soft-tissue reconstruction.
Key Metrics of Influence:
- Publication Volume: 400+ peer-reviewed articles.
- Research Focus: Expert in both surgical and nonsurgical interventions for cancer-related lymphedema.
- Academic Reach: Joint appointments and professorships that bridge clinical practice at MSK with medical education at Weill Cornell.
- Funding Oversight: Directorship of NIH-funded research, signaling his high standing with federal grant-making bodies.
These metrics are not merely academic honors; they represent a body of work that has directly influenced clinical protocols. His research into the lymphatic system has shifted the paradigm from palliative management of lymphedema to active, restorative surgical interventions, giving hope to patients who previously had few options for recovery.
Official Responses: A Vision for the Future
Upon assuming his new role, Dr. Mehrara articulated a vision that balances the preservation of the Foundation’s legacy with the necessity of bold, forward-looking innovation.
"It’s an honor to lead The PSF, and I look forward to building on its legacy of excellence in plastic surgery research and innovation," Dr. Mehrara stated. "I am deeply committed to the advancement of scientific discovery and supporting the work of residents, early-career researchers, and emerging innovators."
His emphasis on the "early-career" researcher is particularly significant. In an era where the cost of medical research is rising and the competition for grants is fierce, Dr. Mehrara intends to use his platform to ensure that the brightest minds in the field remain within the specialty of plastic surgery. By championing mentorship programs and increasing the accessibility of research funding, he aims to create a sustainable pipeline of talent.
"Throughout my presidency," he added, "I will champion new ways to strengthen and expand The Foundation’s mission of research and education."
Implications: The Future of Plastic Surgery
The appointment of Dr. Mehrara signals that The Plastic Surgery Foundation is leaning into a more research-intensive, data-driven future. Under his leadership, the Foundation is expected to pivot toward several strategic priorities that will have long-term implications for the field:
1. The Integration of Regenerative Medicine
Dr. Mehrara’s background in lymphatic biology is inextricably linked to regenerative medicine. As president, he is expected to push for more research into how tissue-engineered constructs can replace traditional reconstructive methods, potentially reducing the need for invasive donor-site surgeries.
2. Global Partnerships and Equitable Access
The mandate to "expand access to safe, effective, and affordable plastic surgery care" is a complex challenge. Dr. Mehrara’s international recognition suggests that The PSF will likely increase its efforts to export advanced surgical training to underserved regions. By building global partnerships, the Foundation aims to standardize safe practices and improve outcomes for patients worldwide, regardless of their proximity to high-resource urban centers.
3. Advancing the "Oncoplastic" Standard
As an expert in oncologic reconstruction, Dr. Mehrara is perfectly positioned to integrate the latest cancer research with reconstructive strategies. The implication for the patient is a more seamless experience where the oncologic surgeon and the plastic surgeon work in closer concert, viewing the removal of the tumor and the reconstruction of the anatomy as a singular, unified mission.
4. Strengthening the Economic Viability of Research
Finally, Dr. Mehrara’s experience with NIH funding will be an asset as he works to diversify the Foundation’s revenue streams. By aligning The PSF’s goals with broader public health objectives, he intends to secure the financial future of the Foundation, ensuring that it remains a resilient pillar of support even in fluctuating economic climates.
Conclusion: A Legacy in the Making
As Dr. Mehrara settles into his term, the surgical community will be watching closely. His appointment is more than a change in leadership; it is a declaration of intent. By fostering a culture that prizes both the precision of the scalpel and the rigor of the laboratory, Dr. Mehrara is set to leave an indelible mark on the profession. Whether through the development of new treatments for lymphedema or the cultivation of the next generation of academic surgeons, his presidency promises to be defined by a commitment to the very thing that drives all medicine: the improvement of the human condition through science and compassion.
As of October 2025, the trajectory of The Plastic Surgery Foundation is firmly in the hands of a leader who understands that the future of plastic surgery is not just in how we operate, but in how we investigate, educate, and innovate. With his extensive experience, Dr. Mehrara is poised to guide the organization through a year of growth, discovery, and enduring impact.
About the Author
